Next, we used either ML385 (an inhibitor of the Nrf2/HO-1 pathway) or DMF (an activator of the Nrf2/HO-1 pathway) to treat COPD mice. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.